INARI MEDICAL INC. - COMMON STOCK

Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry

12 3 2024 15:05:00 提供 Nasdaq GlobeNewswire

Inari Medical Reports Fourth Quarter 2023 Financial Results

28 2 2024 15:05:01 提供 Nasdaq GlobeNewswire

Inari Medical to Announce Fourth Quarter and Full Year 2023 Financial Results

14 2 2024 15:05:00 提供 Nasdaq GlobeNewswire

Inari Medical Announces Preliminary 2023 Revenue and 2024 Guidance

09 1 2024 05:30:00 提供 Nasdaq GlobeNewswire

Inari Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference

20 12 2023 15:01:00 提供 Nasdaq GlobeNewswire

Inari Medical Announces First Patient Enrollment in PEERLESS II Randomized Controlled Trial (RCT)

27 11 2023 15:20:00 提供 Nasdaq GlobeNewswire

Inari Medical Closes Acquisition of LimFlow

15 11 2023 15:05:00 提供 Nasdaq GlobeNewswire

Inari Medical to Present at Upcoming Investor Conferences

02 11 2023 15:01:00 提供 Nasdaq GlobeNewswire

Inari Medical Reports Third Quarter 2023 Financial Results

01 11 2023 15:02:00 提供 Nasdaq GlobeNewswire

Inari Medical Expands Its Patient-Focused Mission with Agreement to Acquire LimFlow

01 11 2023 15:01:00 提供 Nasdaq GlobeNewswire

Inari Medical to Announce Third Quarter 2023 Financial Results

11 10 2023 15:01:00 提供 Nasdaq GlobeNewswire

Inari Medical to Present at Upcoming Investor Conferences

24 8 2023 15:01:00 提供 Nasdaq GlobeNewswire

Inari Medical Reports Second Quarter 2023 Financial Results

02 8 2023 15:01:00 提供 Nasdaq GlobeNewswire

Inari Medical to Present at the 43rd Annual Canaccord Growth Conference

26 7 2023 15:01:00 提供 Nasdaq GlobeNewswire

Inari Medical to Announce Second Quarter 2023 Financial Results

13 7 2023 15:01:00 提供 Nasdaq GlobeNewswire

Inari Medical Announces Commercial Launch of RevCore™ and Triever16 Curve™, Two New Purpose-Built Products for Addressing Venous Stent Thrombosis and Venous Thromboembolism

07 6 2023 07:00:01 提供 Nasdaq GlobeNewswire

Inari Medical Announces the Release of 2022 Ethos and Sustainability Report

25 5 2023 15:01:00 提供 Nasdaq GlobeNewswire

Inari Medical Announces PEERLESS II, a Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System vs. Anticoagulation in Pulmonary Embolism Patients

22 5 2023 07:00:01 提供 Nasdaq GlobeNewswire

Inari Medical Reports First Quarter 2023 Financial Results

03 5 2023 15:01:00 提供 Nasdaq GlobeNewswire

Inari Medical to Present at the Bank of America 2023 Healthcare Conference

02 5 2023 15:01:00 提供 Nasdaq GlobeNewswire